Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|7|1183-1189

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.7, 2015-07, pp. : 1183-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sustained virologic response achieved after curative treatment of hepatitis C virus‐related hepatocellular carcinoma as an independent prognostic factor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1197-1204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Prospective liver cancer risk prediction

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 131-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 41-49

Karger

Access to resources Recommend Favorite

Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E240-E251

John Wiley & Sons Inc

Access to resources Recommend Favorite